HNAB Insider Trading Activity and SEC Form 4 Filings
HNAB insider trading summary
No open-market insider purchases or sales of Hana Biosciences Inc (HNAB) have been reported on SEC Form 4 in the past 12 months.
Latest HNAB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 18, 2008 | Paul V Maier | Director | Buy | $5K (7,000 @ $0.75) |
| May 15, 2008 | Michael Weiser | Director | Buy | $3K (4,000 @ $0.85) |
| May 15, 2008 | Michael Weiser | Director | Buy | $5K (6,000 @ $0.84) |
| Dec 31, 2007 | Steven R Deitcher | President and CEO | Buy | $5K (5,000 @ $1.10) |
| Dec 27, 2007 | Steven R Deitcher | President and CEO | Buy | $5K (5,000 @ $1.03) |
| Dec 26, 2007 | Steven R Deitcher | President and CEO | Buy | $5K (5,000 @ $1.07) |
| Dec 24, 2007 | Steven R Deitcher | President and CEO | Buy | $5K (5,000 @ $1.08) |
| Dec 7, 2007 | Isaac Kier | Director | Sell | $9K (8,000 @ $1.16) |
| Dec 6, 2007 | Isaac Kier | Director | Sell | $14K (12,000 @ $1.18) |
| Dec 5, 2007 | Isaac Kier | Director | Sell | $10K (8,100 @ $1.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.